MaxCyte says its clinically validated electroporation technology will help increase efficiency and improve the yield of Allogene’s allogeneic CAR-T therapy candidates. For this to happen, Allogene has constantly stressed the importance of manufacturing,… read more

A french vaccine producer, Valneva SE has recently announced that it has successfully been approved by the US Food and Drug Administration (FDA) to commence its Phase II Clinical Trials and licensure of… read more

A team from the Netherlands, Utrecht University who had managed to contain the SARS virus during the outbreak of 2002 firstly looked at frozen antibodies that recognized the 2002 Severe Acute Respiratory Syndrome… read more

Vaxine Pty Ltd, a clinical-stage biopharmaceutical company based in Australia, specializes in the adjuvant platform technology, behind COVAX-19®, the first COVID-19 vaccine to be developed in the Southern Hemisphere is set to enter… read more

Mesoblast Limited, recently announced that the United States Food and Drug Administration has accepted for priority review the Company’s Biologics License Application filing for RYONCIL, its allogeneic cell therapy for the treatment of… read more

Moderna Therapeutics Norwood, Massachusetts manufacturing plant is a competitive strategic advantage to them as they race to develop and scale-up a vaccine against COVID-19. Moderna released data from its small Phase I study… read more

A team from Massachusetts Institute of Technology and the Polytechnic University of Turin developed a continuous freeze-drier moves vials where a sequence of chambers where the contents are cooled to a uniform temperature,… read more

An international team of scientists led by Camillo Ricordi, M.D., director of the Diabetes Research Institute and Cell Transplant Center at the University of Miami Miller School of Medicine, has been given FDA… read more

University of Maryland School of Medicine researchers assessed various human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising antiviral therapy against the novel… read more

Thermo Fisher Scientific announced that it plans to open a cell therapy development and manufacturing collaboration center in Princeton as part of a $475 million investment in its biopharma capabilities. Thermo Fisher Scientific… read more